Patent Assignment
Reel/Frame 018582/0506
Assignment of Assignor's Interest
Recorded: 2006-11-29
Pages: 5
Assignor
PHYLOS, INC.
Executed: 2003-12-15
Assignee
COMPOUND THERAPEUTICS, INC.
1365 MAIN STREET, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
Pharmaceutically acceptable FN3 polypeptides for human treatments
Application:
11/483,918 →
Publication:
US 2006/0246059
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Aug 7, 2006
From: COMPOUND THERAPEUTICS, INC.
To: ADNEXUS THERAPEUTICS, INC.
Reel/Frame 018061/0643 →
Assignment of Assignor's Interest
Nov 29, 2006
From: LIPOVSEK, DASA; WAGNER, RICHARD W.; KUIMELIS, ROBERT G.
To: PHYLOS, INC.
Reel/Frame 018565/0181 →
Assignment of Assignor's Interest
Nov 29, 2006
From: COMPOUND THERAPEUTICS, INC.
To: ADNEXUS THERAPEUTICS, INC.
Reel/Frame 018582/0485 →
Change of Name
Aug 11, 2008
From: ADNEXUS, A BMS R&D COMPANY
To: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
Reel/Frame 021371/0781 →
Merger
Aug 11, 2008
From: ADNEXUS THERAPEUTICS, INC.
To: ADNEXUS, A BMS R&D COMPANY
Reel/Frame 021428/0782 →
Assignment of Assignor's Interest
Aug 5, 2009
From: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 023056/0255 →